<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="1" ids="50694">Minocycline</z:chebi> is an antibiotic now recognized to have antiapoptotic and antiinflammatory properties </plain></SENT>
<SENT sid="1" pm="."><plain>Because of these properties, <z:chebi fb="1" ids="50694">minocycline</z:chebi> may be of benefit in reducing neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> from <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and subsequent postischemic <z:mp ids='MP_0001845'>inflammation</z:mp> if administered soon after a <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We now explore the feasibility of using (99m)Tc-annexin V, an in vivo marker of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, with SPECT to monitor the antiapoptotic effects of <z:chebi fb="1" ids="50694">minocycline</z:chebi> therapy </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: CB6/F1 adult male mice underwent unilateral distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (dMCA) occlusion and were imaged and sacrificed at 1, 3, 7, or 30 d after injury </plain></SENT>
<SENT sid="4" pm="."><plain>Animals were given <z:chebi fb="1" ids="50694">minocycline</z:chebi> (or vehicle) 30 min and 12 h after dMCA occlusion and then given 22.5 mg/kg twice daily for up to 7 d </plain></SENT>
<SENT sid="5" pm="."><plain>Before imaging, behavioral tests were performed to evaluate the neurologic function </plain></SENT>
<SENT sid="6" pm="."><plain>After imaging, brains were collected for histology and assessed for the degree of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and microglial activation </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: (99m)Tc-Annexin V uptake in injured hemispheres was significantly decreased 2- to 3-fold by <z:chebi fb="1" ids="50694">minocycline</z:chebi> at <z:hpo ids='HP_0000001'>all</z:hpo> time points </plain></SENT>
<SENT sid="8" pm="."><plain>Minocyline reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> size as seen histologically and improved behavioral indices as late as 30 d </plain></SENT>
<SENT sid="9" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume as seen histologically correlated with radiolabeled annexin V uptake seen by SPECT </plain></SENT>
<SENT sid="10" pm="."><plain>In situ fluorescent microscopy demonstrated that annexin V bound primarily to neurons at 1 and 3 d, with a shift toward microglia by 7 and 30 d </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: We found that <z:chebi fb="1" ids="50694">minocycline</z:chebi> significantly reduces neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:mpath ids='MPATH_124'>infarct</z:mpath> size and improves neurologic outcome in mice after <z:hpo ids='HP_0011009'>acute</z:hpo> focal cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>